FTO is overexpressed in specific subtypes of AML, including t(11q23)/MLL‐rearranged AML, t(15;17)/Acute Promyelocytic Leukaemia (APL), and normal karyotype AMLs carrying NPM1 or FLT3‐ITD mutants.88, 89, 90. Here, KMT2A is linked to acute myeloid leukemia.